• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Allogeneic hematopoietic stem cell transplantation in elderly patients with acute myeloid leukemia or myelodysplastic syndromes: myth and reality.

作者信息

Del Galy A Sutra, Marouf A, Raffoux E, Robin M, Michonneau D, Sébert M, Sicre de Fontebrune F, Xhaard A, Lengline E, Itzykson R, Frieri C, Dombret H, Fenaux P, Peffault de Latour R, Adès L, Socié G

机构信息

Hematology-Transplantation, AP-HP Hospital St Louis, Paris, France.

University of Paris, Paris, France.

出版信息

Leukemia. 2021 Jan;35(1):225-228. doi: 10.1038/s41375-020-1004-9. Epub 2020 Jul 30.

DOI:10.1038/s41375-020-1004-9
PMID:32733010
Abstract
摘要

相似文献

1
Allogeneic hematopoietic stem cell transplantation in elderly patients with acute myeloid leukemia or myelodysplastic syndromes: myth and reality.老年急性髓系白血病或骨髓增生异常综合征患者的异基因造血干细胞移植：误区与现实
Leukemia. 2021 Jan;35(1):225-228. doi: 10.1038/s41375-020-1004-9. Epub 2020 Jul 30.
2
Hematopoietic Cell Transplantation Comorbidity Index Predicts Outcomes in Patients with Acute Myeloid Leukemia and Myelodysplastic Syndromes Receiving CD34 Selected Grafts for Allogeneic Hematopoietic Cell Transplantation.造血细胞移植合并症指数可预测接受CD34选择移植物进行异基因造血细胞移植的急性髓系白血病和骨髓增生异常综合征患者的预后。
Biol Blood Marrow Transplant. 2017 Jan;23(1):67-74. doi: 10.1016/j.bbmt.2016.10.017. Epub 2016 Oct 24.
3
Allogeneic transplantation for the elderly patient with acute myelogenous leukemia or myelodysplastic syndrome.老年急性髓系白血病或骨髓增生异常综合征患者的异基因移植。
Semin Hematol. 2006 Apr;43(2):107-17. doi: 10.1053/j.seminhematol.2006.01.004.
4
Prognostic Limitations of Donor T Cell Chimerism after Myeloablative Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndromes.清髓性异基因干细胞移植治疗急性髓系白血病和骨髓增生异常综合征后供体T细胞嵌合状态的预后局限性
Biol Blood Marrow Transplant. 2017 May;23(5):840-844. doi: 10.1016/j.bbmt.2017.01.086. Epub 2017 Feb 6.
5
Transplant for MDS: challenges and emerging strategies.骨髓增生异常综合征的移植：挑战与新出现的策略
Best Pract Res Clin Haematol. 2015 Mar;28(1):43-54. doi: 10.1016/j.beha.2014.11.006. Epub 2014 Dec 4.
6
Durable graft-versus-leukaemia effects without donor lymphocyte infusions - results of a phase II study of sequential T-replete allogeneic transplantation for high-risk acute myeloid leukaemia and myelodysplasia.无需供体淋巴细胞输注的持久移植物抗白血病效应——高危急性髓系白血病和骨髓增生异常综合征序贯全量供体异基因移植II期研究结果
Br J Haematol. 2018 Feb;180(3):346-355. doi: 10.1111/bjh.14980. Epub 2017 Oct 26.
7
Impact of the revised International Prognostic Scoring System, cytogenetics and monosomal karyotype on outcome after allogeneic stem cell transplantation for myelodysplastic syndromes and secondary acute myeloid leukemia evolving from myelodysplastic syndromes: a retrospective multicenter study of the European Society of Blood and Marrow Transplantation.修订后的国际预后评分系统、细胞遗传学和单倍体核型对骨髓增生异常综合征及由骨髓增生异常综合征演变而来的继发性急性髓系白血病异基因干细胞移植后结局的影响：欧洲血液和骨髓移植学会的一项回顾性多中心研究
Haematologica. 2015 Mar;100(3):400-8. doi: 10.3324/haematol.2014.116715. Epub 2014 Dec 31.
8
Outcome of allogeneic stem cell transplantation for AML and myelodysplastic syndrome in elderly patients (⩾60 years).老年患者（≥60岁）急性髓系白血病和骨髓增生异常综合征的异基因干细胞移植结果
Bone Marrow Transplant. 2016 Nov;51(11):1441-1448. doi: 10.1038/bmt.2016.156. Epub 2016 Jun 13.
9
Prognostic factors influencing survival after allogeneic transplantation for AML/MDS patients with mutations.影响伴有突变的急性髓系白血病/骨髓增生异常综合征患者异基因移植后生存的预后因素。
Blood. 2018 Jun 28;131(26):2989-2992. doi: 10.1182/blood-2018-02-832360. Epub 2018 May 16.
10
Multicenter validation of scoring system of pre-transplant serum ferritin and disease risk in patients with acute myeloid leukemia and myelodysplastic syndrome after allogeneic hematopoietic stem cell transplant.异基因造血干细胞移植后急性髓系白血病和骨髓增生异常综合征患者移植前血清铁蛋白评分系统与疾病风险的多中心验证
Leuk Lymphoma. 2013 Jun;54(6):1318-20. doi: 10.3109/10428194.2012.730613. Epub 2012 Nov 1.

引用本文的文献

1
Allogeneic transplantation in acute myelogenous leukemia: a comprehensive single institution's experience.异基因移植治疗急性髓细胞白血病：综合性单机构经验
Haematologica. 2023 Sep 1;108(9):2369-2379. doi: 10.3324/haematol.2023.282729.
2
Cardiopulmonary Exercise Test With Comorbidity Index Before Allogeneic Hematopoietic Stem Cell Transplantation.移植前合并症指数的心肺运动试验。
Integr Cancer Ther. 2022 Jan-Dec;21:15347354221134249. doi: 10.1177/15347354221134249.
3
Life expectancy and burden of late complications after reduced intensity conditioning allogeneic transplantation.
低强度预处理异基因移植后患者的预期寿命和晚期并发症负担。
Bone Marrow Transplant. 2022 Sep;57(9):1365-1372. doi: 10.1038/s41409-022-01715-5. Epub 2022 Jun 2.
4
Current status of clinical trials assessing mesenchymal stem cell therapy for graft versus host disease: a systematic review.评估间充质干细胞治疗移植物抗宿主病的临床试验现状：系统评价。
Stem Cell Res Ther. 2022 Mar 4;13(1):93. doi: 10.1186/s13287-022-02751-0.
5
Evolving Therapeutic Approaches for Older Patients with Acute Myeloid Leukemia in 2021.2021年老年急性髓系白血病患者不断发展的治疗方法
Cancers (Basel). 2021 Oct 11;13(20):5075. doi: 10.3390/cancers13205075.
6
Not all patients with AML over 60 years of age should be offered early allogeneic stem cell transplantation.并非所有60岁以上的急性髓系白血病患者都应接受早期异基因干细胞移植。
Blood Adv. 2022 Mar 8;6(5):1623-1627. doi: 10.1182/bloodadvances.2021004799.
7
How old is too old for a transplant?对于移植来说，年龄多大算太大了？
Best Pract Res Clin Haematol. 2021 Mar;34(1):101243. doi: 10.1016/j.beha.2021.101243. Epub 2021 Jan 12.